Aberrant FHIT transcripts in hepatocellular carcinomas
1998

Abnormal FHIT Gene Transcripts in Liver Cancer

Sample size: 18 publication Evidence: moderate

Author Information

Author(s): Y-J Chen, P-H Chen, J-G Chang

Primary Institution: Taipei Medical College Hospital

Hypothesis

The study investigates the presence of abnormalities in the FHIT gene in hepatocellular carcinoma (HCC).

Conclusion

Abnormalities of the FHIT gene transcripts occur frequently in both tumorous and non-tumorous liver tissues, but they may not be causally related to hepatocarcinogenesis.

Supporting Evidence

  • Abnormal FHIT transcripts were found in 66.7% of HCC tissues and 44.4% of non-tumorous liver tissues.
  • Normal-sized FHIT transcripts were present in all but one tumorous tissue examined.
  • Previous studies have shown FHIT abnormalities in various cancers, suggesting a broader relevance.

Takeaway

The study looked at liver cancer and found that some genes were not working right, but that doesn't mean they cause cancer.

Methodology

The study analyzed liver cancer cell lines and tissues using microsatellite polymorphism analysis and reverse transcription followed by PCR.

Limitations

The study did not detect any loss of heterozygosity at the examined loci, which may limit the understanding of FHIT's role in cancer.

Participant Demographics

The study included 18 patients with HCC, consisting of 12 men and 6 women, with a mean age of 60.4 years.

Statistical Information

Statistical Significance

p > 0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication